| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 21, 2024 | Option Exercise | $25.30 | 14,491 | 366,622 | 23,061 | Mar 25, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 21, 2024 | Sale | $35.31 | 14,491 | 511,677 | 8,570 | Mar 25, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 20, 2024 | Option Exercise | $25.30 | 400 | 10,120 | 8,970 | Mar 22, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 20, 2024 | Sale | $35.31 | 400 | 14,124 | 8,570 | Mar 22, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 19, 2024 | Sale | $35.31 | 12,364 | 436,573 | 8,570 | Mar 21, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 19, 2024 | Option Exercise | $25.30 | 12,364 | 312,809 | 20,934 | Mar 21, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 13, 2024 | Option Exercise | $17.61 | 62,366 | 1,098,523 | 44,686 | Mar 15, 2024, 06:39 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 13, 2024 | Sale | $33.74 | 62,366 | 2,104,289 | 8,570 | Mar 15, 2024, 06:39 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 12, 2024 | Option Exercise | $12.98 | 3,884 | 50,414 | 12,454 | Mar 14, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 12, 2024 | Sale | $32.99 | 3,884 | 128,133 | 8,570 | Mar 14, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Feb 28, 2024 | Option Exercise | $27.94 | 460 | 12,852 | 7,779 | Feb 29, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 28, 2024 | Option Exercise | $27.94 | 16,788 | 469,057 | 915,217 | Feb 29, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 26, 2024 | Option Exercise | $9.13 | 5,000 | 45,650 | 13,570 | Feb 28, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 26, 2024 | Sale | $30.21 | 5,000 | 151,050 | 8,570 | Feb 28, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Feb 23, 2024 | Option Exercise | $29.06 | 937 | 27,229 | 7,249 | Feb 27, 2024, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 23, 2024 | Option Exercise | $29.06 | 638 | 18,540 | 8,570 | Feb 27, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Feb 23, 2024 | Option Exercise | $29.06 | 1,314 | 38,185 | 7,190 | Feb 27, 2024, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Feb 23, 2024 | Option Exercise | $29.06 | 567 | 16,477 | 4,641 | Feb 27, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 23, 2024 | Option Exercise | $29.06 | 485 | 14,094 | 86,933 | Feb 27, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Feb 22, 2024 | Option Exercise | $27.94 | 303 | 8,466 | 3,958 | Feb 26, 2024, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 22, 2024 | Option Exercise | $27.94 | 372 | 10,394 | 7,958 | Feb 26, 2024, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Feb 22, 2024 | Option Exercise | $27.94 | 335 | 9,360 | 6,311 | Feb 26, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 22, 2024 | Option Exercise | $27.94 | 246 | 6,873 | 86,168 | Feb 26, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10, 2024 | Option Exercise | $9.24 | 8,000 | 73,920 | 93,664 | Jan 12, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10, 2024 | Sale | $27.91 | 8,000 | 223,280 | 85,664 | Jan 12, 2024, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | Sr. VP, Chief Medical Officer | Dec 22, 2023 | Option Exercise | $27.66 | 204 | 5,643 | 3,243 | Dec 26, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Dec 22, 2023 | Option Exercise | $27.66 | 11,958 | 330,758 | 880,505 | Dec 26, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Nov 16, 2023 | Option Exercise | $9.24 | 7,457 | 68,903 | 119,589 | Nov 20, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Nov 16, 2023 | Sale | $28.01 | 2,500 | 70,025 | 117,089 | Nov 20, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Director | Nov 15, 2023 | Option Exercise | $9.24 | 7,457 | 68,903 | 42,324 | Nov 17, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Director | Nov 15, 2023 | Sale | $28.50 | 9,093 | 259,151 | 38,442 | Nov 17, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Nov 14, 2023 | Sale | $28.13 | 1,110 | 31,224 | 5,681 | Nov 16, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Nov 14, 2023 | Option Exercise | $9.24 | 2,000 | 18,480 | 6,791 | Nov 16, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Oct 13, 2023 | Option Exercise | $26.91 | 1,911 | 51,425 | 5,089 | Oct 13, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sep 07, 2023 | Option Exercise | $32.10 | 1,182 | 37,942 | 7,165 | Sep 07, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Sep 07, 2023 | Option Exercise | $32.10 | 16,804 | 539,408 | 867,463 | Sep 07, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 30, 2023 | Sale | $32.00 | 8,100 | 259,200 | 85,249 | Sep 01, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 30, 2023 | Option Exercise | $23.99 | 8,100 | 194,319 | 93,349 | Sep 01, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 25, 2023 | Sale | $31.59 | 5,135 | 162,215 | 85,249 | Aug 29, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | May 11, 2023 | Option Exercise | $36.47 | 709 | 25,857 | 2,650 | May 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | May 11, 2023 | Option Exercise | $36.47 | 15,005 | 547,232 | 849,267 | May 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Feb 22, 2023 | Option Exercise | $38.57 | 193 | 7,444 | 1,148 | Apr 12, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | Feb 22, 2023 | Option Exercise | $38.57 | 289 | 11,147 | 9,228 | Apr 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Feb 22, 2023 | Option Exercise | $38.57 | 289 | 11,147 | 90,034 | Apr 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | Mar 14, 2023 | Option Exercise | $38.65 | 789 | 30,495 | 2,052 | Apr 10, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | Mar 14, 2023 | Sale | $35.99 | 4,780 | 172,023 | 4,737 | Mar 16, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Feb 16, 2023 | Option Exercise | $38.74 | 753 | 29,171 | 8,191 | Feb 21, 2023, 05:35 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 03, 2023 | Sale | $42.02 | 200 | 8,404 | 804,272 | Feb 06, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 02, 2023 | Option Exercise | $9.56 | 22,515 | 215,243 | 817,674 | Feb 06, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 02, 2023 | Sale | $42.06 | 13,532 | 569,088 | 804,142 | Feb 06, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 03, 2023 | Option Exercise | $9.56 | 330 | 3,155 | 804,472 | Feb 06, 2023, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 01, 2023 | Option Exercise | $9.56 | 498 | 4,761 | 795,459 | Feb 03, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Feb 01, 2023 | Sale | $42.01 | 300 | 12,602 | 795,159 | Feb 03, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 31, 2023 | Option Exercise | $9.56 | 1,620 | 15,487 | 795,937 | Feb 02, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 31, 2023 | Sale | $42.01 | 976 | 41,002 | 794,961 | Feb 02, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 18, 2023 | Option Exercise | $9.56 | 8,080 | 77,245 | 799,253 | Jan 20, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 18, 2023 | Sale | $40.40 | 4,936 | 199,394 | 794,317 | Jan 20, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Jan 17, 2023 | Option Exercise | $9.13 | 4,826 | 44,061 | 6,470 | Jan 19, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Jan 17, 2023 | Sale | $39.92 | 4,826 | 192,638 | 1,644 | Jan 19, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 17, 2023 | Sale | $40.03 | 25,446 | 1,018,728 | 791,173 | Jan 19, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Jan 17, 2023 | Option Exercise | $9.56 | 41,920 | 400,755 | 816,619 | Jan 19, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Director | Jan 10, 2023 | Option Exercise | $7.90 | 8,722 | 68,904 | 30,985 | Jan 12, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Jan 06, 2023 | Sale | $39.90 | 174 | 6,943 | 1,644 | Jan 09, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Jan 06, 2023 | Option Exercise | $9.13 | 174 | 1,589 | 1,818 | Jan 09, 2023, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Director | Dec 28, 2022 | Option Exercise | $7.90 | 8,722 | 68,904 | 110,453 | Dec 30, 2022, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Dec 20, 2022 | Sale | $38.02 | 4,006 | 152,317 | 791,956 | Dec 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Dec 21, 2022 | Option Exercise | $9.56 | 18,472 | 176,592 | 826,053 | Dec 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Dec 21, 2022 | Sale | $38.14 | 11,354 | 433,070 | 814,699 | Dec 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Dec 20, 2022 | Option Exercise | $9.56 | 6,528 | 62,408 | 795,962 | Dec 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Dec 01, 2022 | Option Exercise | $9.13 | 5,000 | 45,650 | 6,644 | Dec 02, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Dec 01, 2022 | Sale | $37.48 | 5,000 | 187,416 | 1,644 | Dec 02, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 23, 2022 | Sale | $35.05 | 2,259 | 79,189 | 782,775 | Nov 28, 2022, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 25, 2022 | Option Exercise | $9.56 | 17,794 | 170,111 | 800,569 | Nov 28, 2022, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 25, 2022 | Sale | $35.18 | 11,135 | 391,685 | 789,434 | Nov 28, 2022, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 23, 2022 | Option Exercise | $9.56 | 3,616 | 34,569 | 785,034 | Nov 28, 2022, 05:02 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 22, 2022 | Option Exercise | $9.56 | 959 | 9,168 | 782,018 | Nov 23, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 22, 2022 | Sale | $35.00 | 600 | 21,001 | 781,418 | Nov 23, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 21, 2022 | Option Exercise | $9.56 | 848 | 8,107 | 781,590 | Nov 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 21, 2022 | Sale | $35.01 | 531 | 18,592 | 781,059 | Nov 22, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 15, 2022 | Option Exercise | $9.56 | 1,783 | 17,045 | 781,857 | Nov 17, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Nov 15, 2022 | Sale | $35.00 | 1,115 | 39,028 | 780,742 | Nov 17, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Nov 11, 2022 | Option Exercise | $9.24 | 6,800 | 62,832 | 8,444 | Nov 15, 2022, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Nov 11, 2022 | Sale | $34.95 | 6,800 | 237,655 | 1,644 | Nov 15, 2022, 05:01 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Nov 09, 2022 | Sale | $34.97 | 700 | 24,480 | 1,644 | Nov 14, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Nov 09, 2022 | Option Exercise | $9.24 | 700 | 6,468 | 2,344 | Nov 14, 2022, 05:00 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Sep 14, 2022 | Option Exercise | $33.75 | 1,380 | 46,575 | 780,074 | Sep 15, 2022, 05:15 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 22, 2022 | Option Exercise | $7.90 | 5,000 | 39,500 | 92,220 | Aug 23, 2022, 05:16 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 22, 2022 | Sale | $35.98 | 5,000 | 179,900 | 87,220 | Aug 23, 2022, 05:16 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Aug 16, 2022 | Option Exercise | $34.01 | 9,182 | 312,307 | 790,249 | Aug 18, 2022, 05:15 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Aug 16, 2022 | Sale | $34.01 | 14,690 | 499,651 | 775,559 | Aug 18, 2022, 05:15 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Aug 10, 2022 | Sale | $31.22 | 28,437 | 887,803 | 741,441 | Aug 11, 2022, 05:15 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Aug 09, 2022 | Sale | $31.15 | 39,431 | 1,228,276 | 724,978 | Aug 10, 2022, 05:25 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | Aug 08, 2022 | Sale | $31.46 | 117,907 | 3,709,402 | 711,341 | Aug 09, 2022, 05:25 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 04, 2022 | Option Exercise | $7.90 | 5,000 | 39,500 | 92,220 | Aug 05, 2022, 04:31 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Aug 04, 2022 | Sale | $32.98 | 5,000 | 164,900 | 87,220 | Aug 05, 2022, 04:31 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | SIEBERT JOHN M | Director | Aug 11, 2021 | Option Exercise | $12.98 | 15,000 | 194,700 | 75,953 | Aug 12, 2021, 04:32 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 13, 2021 | Option Exercise | $12.98 | 3,125 | 40,562 | 89,451 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 13, 2021 | Sale | $29.98 | 3,125 | 93,702 | 86,326 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 14, 2021 | Option Exercise | $12.98 | 3,125 | 40,562 | 89,451 | Apr 14, 2021, 08:24 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Apr 14, 2021 | Sale | $31.98 | 3,125 | 99,937 | 86,326 | Apr 14, 2021, 08:24 PM |
Menu